Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Clinical Lab Management › Quest to Offer Thermo Fisher's Oncomine Dx Target Test

Quest to Offer Thermo Fisher's Oncomine Dx Target Test

Feb 06, 2018
|
staff reporter

NEW YORK (360Dx) – Quest Diagnostics announced today that it has partnered with Thermo Fisher Scientific to offer the company's next-generation sequencing-based companion diagnostic panel for non-small cell lung cancer.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Nov
10
Featured Webinar

IVDR in Light of the COVID Pandemic: The Near Future of In Vitro Diagnostic Testing

Sponsored by
LGC

The COVID-19 pandemic created a paradigm shift in modern healthcare, where regulations, protocols, and mindsets had to be reworked in just a matter of months to keep up with the pace of the virus.

What's Popular?

In Clinical Lab Management

  1. CMS Changes Reimbursement Rates to Accelerate COVID-19 Testing

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.